Baupost Group
13F Holdings and Portfolio Analysis
Seth Klarman 2019 Q4 13F holdings, quarterly changes, portfolio value trend and position weight distribution.
Baupost Group Overview
Baupost Group held 31 stocks in 2019 Q4, with total market value around $9.06B.
Baupost Group's top five holdings in 2019 Q4: LIBERTY GLOBAL PLC SHS CL C(LBTYA) 12.61%, FOX CORP - CLASS A(FOXA) 11.19%, VIASAT INC(VSAT) 11.10%, EBAY INC. COM(EBAY) 7.97%, PARAMOUNT GLOBAL CLASS B COM(PSKY) 7.88%.
- Portfolio Value
- $9.06B
- Current Holdings
- 31 stocks
- New / Increased
- 4 / 3
- Reduced / Exited
- 7 / 5
Current Holdings
| 1 | LIBERTY GLOBAL PLC SHS CL CLBTYA | 1.14 | 12.61% | 52.39 +19.19% | $21.80 | - | $15.52 | +8.43 | 1.50 | +$0.33B+40.47% | Increased |
| 2 | FOX CORP - CLASS AFOXA | 1.01 | 11.19% | 27.32 - | $37.07 | - | $36.71 | 0.00 | 1.00 | +$0.01B+0.98% | Held |
| 3 | VIASAT INCVSAT | 1.01 | 11.10% | 13.73 - | $73.19 | - | $70.34 | 0.00 | 6.75 | +$0.04B+4.07% | Held |
| 4 | EBAY INC. COMEBAY | 0.72 | 7.97% | 19.99 +20.12% | $36.11 | - | $31.55 | +3.35 | 1.25 | +$0.09B+14.44% | Increased |
| 5 | PARAMOUNT GLOBAL CLASS B COMPSKY | 0.71 | 7.88% | 17.00 | $41.97 | - | $41.97 | +17.00 | 0.25 | $0.00B0.00% | New |
| 6 | CHENIERE ENERGY INCCUSIP 16411R208 | 0.62 | 6.84% | 10.14 - | $61.07 | - | $64.49 | 0.00 | 6.00 | -$0.03B-5.30% | Held |
| 7 | TESLA INC CV SR UNSEC NTCUSIP 88160RAD3可转换债券 | 0.42 | 4.65% | 300.00 - | $1.41 | - | $1.16 | 0.00 | 2.00 | +$0.07B+20.90% | Held |
| 8 | QORVO INCCUSIP 74736K101 | 0.32 | 3.53% | 2.75 -51.59% | $116.23 | - | $134.68 | -2.93 | 3.00 | -$0.05B-13.70% | Reduced |
| 9 | BRISTOL-MYERS SQUIBB COBMY | 0.26 | 2.84% | 4.00 -60.00% | $64.19 | - | $46.08 | -6.00 | 1.00 | +$0.07B+39.31% | Reduced |
| 10 | THERAVANCE BIOPHARMA INCCUSIP G8807B106 | 0.24 | 2.66% | 9.31 - | $25.89 | - | $30.35 | 0.00 | 5.75 | -$0.04B-14.70% | Held |
| 11 | COLONY CAP INC NEWCUSIP 19626G108 | 0.24 | 2.61% | 49.69 - | $4.75 | - | $6.24 | 0.00 | 1.75 | -$0.07B-23.88% | Held |
| 12 | NEXSTAR MEDIA GROUP INCCUSIP 65336K103 | 0.23 | 2.59% | 2.00 - | $117.25 | - | $90.96 | 0.00 | 1.25 | +$0.05B+28.91% | Held |
| 13 | UNIVAR INC COMCUSIP 91336L107 | 0.23 | 2.54% | 9.50 - | $24.24 | - | $6.92 | 0.00 | 1.50 | +$0.16B+250.31% | Held |
| 14 | MCKESSON CORP COMMCK | 0.22 | 2.44% | 1.60 +22.32% | $138.32 | $742.44 +436.76% | $136.22 | +0.29 | 2.50 | +$0.97B+445.04% | Increased |
| 15 | FOX CORP - CLASS BFOX | 0.21 | 2.28% | 5.68 - | $36.40 | - | $35.88 | 0.00 | 1.00 | +$0.00B+1.45% | Held |
| 16 | HP Inc.HPQ | 0.21 | 2.27% | 10.00 | $20.55 | $27.48 +33.75% | $20.55 | +10.00 | 0.25 | +$0.07B+33.75% | New |
| 17 | P G & E CORPPCG | 0.21 | 2.27% | 18.89 -22.91% | $10.87 | - | $29.62 | -5.61 | 2.00 | -$0.35B-63.31% | Reduced |
| 18 | LIBERTY GLOBAL PLC SHS CL ALBTYA | 0.17 | 1.92% | 7.66 - | $22.74 | - | $28.18 | 0.00 | 1.50 | -$0.04B-19.31% | Held |
| 19 | TRANSLATE BIO INCCUSIP 89374L104 | 0.14 | 1.56% | 17.54 - | $8.06 | - | $5.50 | 0.00 | 1.75 | +$0.04B+46.43% | Held |
| 20 | ATARA BIOTHERAPEUTICS INCCUSIP 046513107 | 0.14 | 1.51% | 8.31 - | $16.47 | - | $29.07 | 0.00 | 5.25 | -$0.10B-43.33% | Held |
| 21 | AKEBIA THERAPEUTICS INCCUSIP 00972D105 | 0.12 | 1.37% | 19.57 -20.02% | $6.32 | - | $5.53 | -4.90 | 1.25 | +$0.02B+14.29% | Reduced |
| 22 | Synchrony FinancialSYF | 0.11 | 1.19% | 3.00 -39.97% | $36.01 | $72.84 +102.28% | $29.47 | -2.00 | 3.50 | +$0.13B+147.16% | Reduced |
| 23 | AMERISOURCEBERGEN CORPCUSIP 03073E105 | 0.10 | 1.10% | 1.17 - | $85.02 | - | $88.34 | 0.00 | 2.50 | -$0.00B-3.76% | Held |
| 24 | VERITIV CORPCUSIP 923454102 | 0.07 | 0.77% | 3.56 - | $19.67 | - | $43.60 | 0.00 | 5.50 | -$0.09B-54.88% | Held |
| 25 | VISTA ENERGY SAB DE CV COMMON STOCKVIST | 0.05 | 0.54% | 6.17 - | $7.85 | - | $5.17 | 0.00 | 0.50 | +$0.02B+51.84% | Held |
Showing 1-25 of 31
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis is an estimate and can differ materially from the actual cost, especially in edge cases.
Cost basis estimate: from the latest uninterrupted holding period, new or increased shares are added to the cost pool at the report price; reductions remove shares at the then-average cost. Example: buy 100 shares at $10 in Q1 and add 50 shares at $16 in Q2, estimated cost basis is (100 x 10 + 50 x 16) / 150 = $12 per share.
Return shows estimated dollar return on top and percentage return below. It uses current price when available, otherwise report price.
Exited Holdings
Stocks no longer disclosed in the current 13F portfolio for 2019 Q4.
| 1 | CBS CORP NEW CL BCUSIP 124857202 | 12.00 | 1.00 | $45.82 | $40.37 | -$0.07B-11.89% |
| 2 | TAKEDA PHARMACEUTICAL CO LTDCUSIP 874060205 | 9.43 | 0.75 | $20.37 | $17.20 | -$0.03B-15.56% |
| 3 | ANTERO RES CORPCUSIP 03674X106 | 21.09 | 5.25 | $16.39 | $3.02 | -$0.28B-81.58% |
| 4 | Gossamer Bio, Inc.GOSS | 0.97 | 0.75 | $20.61 | $15.63 | -$0.00B-24.15% |
| 5 | PARATEK PHARMACEUTICALS INCCUSIP 699374302 | 2.39 | 5.00 | $29.51 | $4.32 | -$0.06B-85.36% |
Showing 1-5 of 5
Exited holdings are stocks disclosed in the previous report period but no longer disclosed in the current 13F portfolio.
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis uses the same weighted cost-pool method as current holdings. Estimated exit price uses the current report period weighted report price when available, otherwise the previous report price; it does not represent the actual sale price.
Exit return shows estimated dollar return on top and percentage return below.
Portfolio Visuals
Track portfolio value, position weights and Top 10 history.